SG48022A1 - Thioxanthenone antitumor agents - Google Patents
Thioxanthenone antitumor agentsInfo
- Publication number
- SG48022A1 SG48022A1 SG1996006225A SG1996006225A SG48022A1 SG 48022 A1 SG48022 A1 SG 48022A1 SG 1996006225 A SG1996006225 A SG 1996006225A SG 1996006225 A SG1996006225 A SG 1996006225A SG 48022 A1 SG48022 A1 SG 48022A1
- Authority
- SG
- Singapore
- Prior art keywords
- antitumor agents
- thioxanthenone
- thioxanthenone antitumor
- thioxanthenones
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
- C07D335/12—Thioxanthenes
- C07D335/14—Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D335/16—Oxygen atoms, e.g. thioxanthones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/713,172 US5091410A (en) | 1991-06-10 | 1991-06-10 | Thioxanthenone antitumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG48022A1 true SG48022A1 (en) | 1998-04-17 |
Family
ID=24865076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996006225A SG48022A1 (en) | 1991-06-10 | 1992-06-03 | Thioxanthenone antitumor agents |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5091410A (ja) |
| EP (1) | EP0518413B1 (ja) |
| JP (1) | JP3045355B2 (ja) |
| AT (1) | ATE146172T1 (ja) |
| AU (1) | AU643138B2 (ja) |
| CA (1) | CA2070799C (ja) |
| DE (1) | DE69215761T2 (ja) |
| DK (1) | DK0518413T3 (ja) |
| ES (1) | ES2098435T3 (ja) |
| GR (1) | GR3022725T3 (ja) |
| IE (1) | IE78824B1 (ja) |
| MX (1) | MX9202752A (ja) |
| SG (1) | SG48022A1 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU642596B2 (en) * | 1991-06-10 | 1993-10-21 | Sanofi-Synthelabo | Thioxanthenone antitumor agents |
| US5346917A (en) * | 1991-06-10 | 1994-09-13 | Sterling Winthrop Inc. | Thioxanthenone antitumor agents |
| US5665760A (en) * | 1995-09-18 | 1997-09-09 | Sanofi Winthrop, Inc. | Lyophilized thioxanthenone antitumor agents |
| US10842776B2 (en) * | 2016-06-28 | 2020-11-24 | Assistance Publique—Hopitaua de Paris | Hycanthone derivatives and Primaquine derivatives for use in the prevention and/or the treatment of disorders associated to gammaherpesvirus |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3577441A (en) * | 1967-03-07 | 1971-05-04 | Warner Lambert Pharmaceutical | Nitro substituted benzofurans |
| US3577558A (en) * | 1968-04-15 | 1971-05-04 | Sterling Drug Inc | 1-aminoalkylamino-4-alkoxymethylthioxanthene derivatives |
| US4539412A (en) * | 1982-07-08 | 1985-09-03 | Rensselaer Polytechnic Institute | 7-Hydroxylucanthone, 7-hydroxhycanthone and their analogs |
| US4582851A (en) * | 1984-02-06 | 1986-04-15 | Warner-Lambert Company | Anti-bacterial 1,4-aminoalkylamino-9H-thioxanthen-9-one derivatives, compositions, and method of use therefor |
| AU642596B2 (en) * | 1991-06-10 | 1993-10-21 | Sanofi-Synthelabo | Thioxanthenone antitumor agents |
-
1991
- 1991-06-10 US US07/713,172 patent/US5091410A/en not_active Expired - Lifetime
-
1992
- 1992-05-21 AU AU17045/92A patent/AU643138B2/en not_active Ceased
- 1992-06-03 AT AT92201586T patent/ATE146172T1/de not_active IP Right Cessation
- 1992-06-03 ES ES92201586T patent/ES2098435T3/es not_active Expired - Lifetime
- 1992-06-03 DK DK92201586.2T patent/DK0518413T3/da active
- 1992-06-03 EP EP92201586A patent/EP0518413B1/en not_active Expired - Lifetime
- 1992-06-03 DE DE69215761T patent/DE69215761T2/de not_active Expired - Fee Related
- 1992-06-03 SG SG1996006225A patent/SG48022A1/en unknown
- 1992-06-08 JP JP4147330A patent/JP3045355B2/ja not_active Expired - Fee Related
- 1992-06-09 MX MX9202752A patent/MX9202752A/es not_active IP Right Cessation
- 1992-06-09 CA CA002070799A patent/CA2070799C/en not_active Expired - Fee Related
- 1992-07-01 IE IE921872A patent/IE78824B1/en not_active IP Right Cessation
-
1997
- 1997-03-03 GR GR970400416T patent/GR3022725T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5091410A (en) | 1992-02-25 |
| IE921872A1 (en) | 1992-12-16 |
| EP0518413B1 (en) | 1996-12-11 |
| AU1704592A (en) | 1992-12-17 |
| ATE146172T1 (de) | 1996-12-15 |
| CA2070799A1 (en) | 1992-12-11 |
| JP3045355B2 (ja) | 2000-05-29 |
| JPH05262760A (ja) | 1993-10-12 |
| DE69215761T2 (de) | 1997-06-05 |
| DK0518413T3 (da) | 1997-06-02 |
| GR3022725T3 (en) | 1997-06-30 |
| MX9202752A (es) | 1994-05-31 |
| EP0518413A1 (en) | 1992-12-16 |
| AU643138B2 (en) | 1993-11-04 |
| DE69215761D1 (de) | 1997-01-23 |
| IE78824B1 (en) | 1998-02-25 |
| CA2070799C (en) | 2005-11-29 |
| ES2098435T3 (es) | 1997-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG17765A (en) | Method of treating tumors in mammals | |
| DE69626513D1 (en) | Imidazolverbindungen | |
| EP0871494A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR CELLS | |
| EP0709090A3 (en) | Compositions for the treatment of resistant tumors | |
| CY2431B1 (en) | Novel phenanthridines substituted in the 6 position. | |
| EP0758196A4 (en) | COMPOSITIONS AND METHODS FOR TREATING TUMORS | |
| EP0730449A4 (en) | NOVEL PALLADIUM COMPLEXES AND METHODS OF USE THEREOF IN THE TREATMENT OF TUMORS AND PSORIASIS | |
| IL114119A0 (en) | Compositions and methods for the treatment of tumors | |
| GR3022725T3 (en) | Thioxanthenone antitumor agents | |
| AU1888692A (en) | Composition and method for treating tumors | |
| GB9010058D0 (en) | Method and composition for the treatment of cancer | |
| GB2185017A (en) | Seco-sterol compounds effective in inducing the differentiation of malignant cells | |
| IL106763A0 (en) | Pharmaceutical compositions for treating cancer | |
| HK51694A (en) | Composition for treating pigmentation | |
| GB9217547D0 (en) | Leather treatment compositions | |
| GB9024861D0 (en) | Bis-dioxopiperazines for treating liver tumors | |
| PL322103A1 (en) | Benzopyraneindodiazolic anticaecinogenic agents | |
| GB2312375B (en) | Agents for treatment of cancer | |
| IL113444A0 (en) | Compositions and methods for treating leukemia | |
| AU7477791A (en) | Method for treating cancer using combination chemotherapy and brm | |
| HU206980B (en) | Process for producing composition suitable for treating phlebectasia and haemorrhoidal tumors | |
| ZA947964B (en) | Compositions and methods for treating pathologies including cancer |